New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
11:29 EDTLH, BRLI, DGXFDA announces steps to ensure reliable diagnostic test results
The FDA announced that it took "important steps to ensure that certain tests used by health care professionals to help diagnose and treat patients provide accurate, consistent and reliable results." The FDA issued a final guidance on the development, review and approval of companion diagnostics, which are tests used to identify patients who will benefit from or be harmed by treatment with a certain drug. Companion diagnostic tests are intended to aid physicians in selecting appropriate therapies for individual patients, the agency said. These tests are commonly used to detect certain types of gene-based cancers. The FDA also is notifying Congress of its intention to publish a proposed risk-based oversight framework for laboratory developed tests, which are designed, manufactured and used within a single laboratory. The agency also intends to publish a draft guidance outlining how laboratories can notify the FDA that they are currently manufacturing and using LDTs, how to provide information about their LDTs, and how they can comply with the medical device reporting requirements. Publicly traded laboratory companies include LabCorp (LH), Quest Diagnostics (DGX) and Bio-Reference Labs (BRLI). Reference Link
News For LH;DGX;BRLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 23, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:25 EDTLH, DGXPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
06:13 EDTDGXQuest Diagnostics downgraded to Neutral from Buy at Goldman
Subscribe for More Information
June 21, 2015
14:16 EDTBRLIOPKO Health shares look pricey, Barron's says
Investors should steer clear of OPKO Health (OPK) and Bio-Reference Labs (BRLI) in light of their recent merger agreement, Barron's contends in a feature article. Though OPKO hopes to push its prostate cancer test, similar products have performed poorly on the market, and Barron's advises "only those who believe that [CEO and chairman Phillip Frost] can work miracles" to own the stock. Reference Link
June 18, 2015
12:07 EDTLHLabCorp management to meet with Craig Hallum
Meetings to be held in Minneapolis/New York June 22-23 hosted by Craig Hallum.
June 16, 2015
10:01 EDTDGX, LHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:17 EDTLHLabCorp initiated with an Overweight at KeyBanc
Subscribe for More Information
06:15 EDTDGXQuest Diagnostics initiated with a Sector Weight at KeyBanc
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use